Antigen-binding proteins targeting S. aureus ORF0657n

Details for Australian Patent Application No. 2008294038 (hide)

Owner Merck & Co., Inc.

Inventors McNeely, Tessie; An, Zhiqiang; Cope, Leslie D.; Anderson, Annaliesa S.; Secore, Susan L.; Durr, Eberhard; Clark, Desmond J.; Wang, Fubao

Agent Spruson & Ferguson

Pub. Number AU-A-2008294038

PCT Pub. Number WO2009/029132

Priority 60/932,788 31.05.07 US; 61/007,998 17.12.07 US

Filing date 29 May 2008

Wipo publication date 5 March 2009

International Classifications

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/31 (2006.01) Peptides having more than 20 amino acids

Event Publications

3 December 2009 PCT application entered the National Phase

  PCT publication WO2009/029132 Priority application(s): WO2009/029132

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. 2009

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008294046-Natural gas liquefaction process

2008294036-Raccoon poxvirus expressing genes of porcine virus